1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. LUPIN LTD.
Lupin Ltd. NSE: LUPIN | BSE: 500257

Lupin Live Share Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
In 1 Starfolio Basket
about

Established in 1968, Lupin is a global pharmaceutical company focused on developing and distributing a diverse range of healthcare products. Its portfolio includes generics, branded generics, complex generics, APIs, biosimilars, and specialty medicin...

Read More
2314.00 21.80 (0.95%)
New 52W High today
657.0K
NSE+BSE Volume

NSE 26 Feb, 2026 1:45 PM (IST)

Watchlist

Portfolio

Alert
US FDA Approval
Lupin gets US FDA approval for a partial-seizure treatment drug, with US sales of ~$135 million See details
Loading... You have run out of DVM views!
Subscribe now to see details
Durability score
High Financial Strength
- / 100
Valuation Score
Mid Valuation
- / 100
Momentum Score
Technically Moderately Bullish
66.7 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM
Analyst Price Target
2,426
1Yr Price target upside is 5%
38 analysts

33

S

2

W

6

O

2

T

SWOT Analysis

Lupin Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..
Is Lupin Ltd. worth buying?
936 Votes:
Buy 72.86%
Sell 17.52%
Hold 9.62%
BUY
SELL
HOLD